During the past decade, Clackamas Radiation Oncology Center conducted 155 clinical trials. In the 10-year time frame, 155 clinical trials started and 104 clinical trials were completed, i.e. on average, 67.1% percent of trials that started reached the finish line to date. In the past 5 years, 68 clinical trials started and 66 clinical trials were completed. i.e. 97.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clackamas Radiation Oncology Center" #1 sponsor was "National Cancer Institute (NCI)" with 115 trials, followed by "SWOG Cancer Research Network" with 49 trials sponsored, "Alliance for Clinical Trials in Oncology" with 41 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored and "Radiation Therapy Oncology Group" with 18 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clackamas Radiation Oncology Center" #1 collaborator was "National Cancer Institute (NCI)" with 139 trials as a collaborator, "NRG Oncology" with 32 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Genentech, Inc." with 3 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Clackamas Radiation Oncology Center" are "Breast Cancer" (17 trials), "Lymphoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Invasive Breast Carcinoma" (8 trials) and "Recurrent Breast Carcinoma" (8 trials). Many other conditions were trialed in "Clackamas Radiation Oncology Center" in a lesser frequency.

Most popular intervention types in "Clackamas Radiation Oncology Center" are "Drug" (204 trials), "Other" (143 trials), "Biological" (105 trials), "Procedure" (65 trials) and "Radiation" (48 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (68 trials), "Quality-of-Life Assessment" (53 trials), "Questionnaire Administration" (36 trials), "Computed Tomography" (35 trials) and "Biospecimen Collection" (34 trials). Other intervention names were less common.

The vast majority of trials in "Clackamas Radiation Oncology Center" are 208 trials for "All" genders, 42 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Clackamas Radiation Oncology Center". undefined are not yet recruiting, 67 are recruiting, 111 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 60 completed trials in Clackamas Radiation Oncology Center, 6 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Clackamas Radiation Oncology Center, 10 "Phase 1" clinical trials were conducted, 125 "Phase 2" clinical trials and 125 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".